Department of Oncology, Hebei Provincial Hospital, No. 348, West Heping Road, Shijiazhuang, Hebei 050051, China.
Math Biosci Eng. 2020 Nov 12;17(6):8074-8083. doi: 10.3934/mbe.2020409.
ObjectThe current study was performed to construct a model with microRNA (miRNA/miR) expression profile and TNM staging system for prognosis predicting in patients with lung adenocarcinoma (LUAD). MethodsDifferentially expressed miRNAs were identified from miRNA data of LUAD in The Cancer Genome Atlas (TCGA) database. Potential prognostic miRNAs and TNM classification parameters, screened out by Cox proportional hazards regression analysis, were included in the prognostic model. The prognostic model was visualized with a nomogram, and tested by calculating the C-index and drawing the calibration curve in the training set and validating set, respectively. Finally, the prognostic miRNAs were analyzed with bioinformatics tools. ResultsA total of 194 differentially expressed miRNAs were identified between LUAD tissues and matched normal tissues, including 99 up-regulated and 95 down-regulated miRNAs. miRNA index (miR.index), constructed with nine miRNAs (hsa-let-7i, hsa-mir-1976, hsa-mir-199a-1, hsa-mir-31, hsa-mir-3940, hsa-mir-450a-2, hsa-mir-4677, hsa-mir-548v and hsa-mir-6803), was an independent prognostic indicator for the survival of patients with LUAD. Bioinformatics analysis suggests that the selected miRNAs are involved in the development and progress of LUAD. ConclusionThe prognostic model constructed with nine miRNA expression profile and TNM classification parameters can predict the survival in patients with LUAD, and the predictive power of the model are warranted for further validations.
目的 本研究旨在构建一个基于微 RNA(miRNA/miR)表达谱和 TNM 分期系统的模型,用于预测肺腺癌(LUAD)患者的预后。
方法 从癌症基因组图谱(TCGA)数据库中 LUAD 的 miRNA 数据中鉴定差异表达的 miRNA。通过 Cox 比例风险回归分析筛选出潜在的预后 miRNA 和 TNM 分类参数,并纳入预后模型。通过列线图可视化预后模型,并分别在训练集和验证集中计算 C 指数和绘制校准曲线进行测试。最后,利用生物信息学工具分析预后 miRNA。
结果 共鉴定出 194 个 LUAD 组织与匹配正常组织之间差异表达的 miRNA,包括 99 个上调和 95 个下调 miRNA。miRNA 指数(miR.index)由 9 个 miRNA(hsa-let-7i、hsa-mir-1976、hsa-mir-199a-1、hsa-mir-31、hsa-mir-3940、hsa-mir-450a-2、hsa-mir-4677、hsa-mir-548v 和 hsa-mir-6803)构建,是 LUAD 患者生存的独立预后指标。生物信息学分析表明,所选 miRNA 参与了 LUAD 的发生和进展。
结论 基于 9 个 miRNA 表达谱和 TNM 分类参数构建的预后模型可预测 LUAD 患者的生存情况,模型的预测能力有待进一步验证。